Genesco (GCO) PT Set at $55.00 by Pivotal Research
Genesco (NYSE:GCO) received a $55.00 target price from equities research analysts at Pivotal Research in a note issued to investors on Monday. The firm presently has a “buy” rating on the stock. Pivotal Research’s price objective suggests a potential upside of 16.40% from the company’s current price.
Several other brokerages also recently issued reports on GCO. CL King downgraded shares of Genesco from a “buy” rating to a “neutral” rating in a report on Tuesday, May 29th. They noted that the move was a valuation call. ValuEngine upgraded Genesco from a “hold” rating to a “buy” rating in a report on Saturday, May 26th. Zacks Investment Research upgraded Genesco from a “sell” rating to a “hold” rating in a report on Friday, August 24th. Piper Jaffray Companies downgraded Genesco from an “overweight” rating to a “neutral” rating and decreased their price objective for the company from $45.90 to $20.90 in a report on Friday, June 1st. They noted that the move was a valuation call. Finally, Jefferies Financial Group downgraded Genesco from a “buy” rating to a “hold” rating and set a $43.00 price objective for the company. in a report on Tuesday, July 10th. Nine analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $38.39.
Shares of NYSE:GCO opened at $47.25 on Monday. The firm has a market cap of $945.97 million, a PE ratio of 15.05, a P/E/G ratio of 1.98 and a beta of 1.06. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.43 and a quick ratio of 0.53. Genesco has a 52-week low of $22.55 and a 52-week high of $51.85.
In related news, Director Kathleen Mason sold 2,000 shares of the stock in a transaction on Thursday, August 30th. The stock was sold at an average price of $48.91, for a total value of $97,820.00. Following the completion of the sale, the director now directly owns 43,626 shares in the company, valued at $2,133,747.66. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 4.30% of the company’s stock.
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Cahaba Wealth Management Inc. grew its holdings in Genesco by 14.9% during the 2nd quarter. Cahaba Wealth Management Inc. now owns 11,095 shares of the company’s stock worth $452,000 after acquiring an additional 1,442 shares during the period. Legal & General Group Plc grew its holdings in Genesco by 3.4% during the 2nd quarter. Legal & General Group Plc now owns 68,849 shares of the company’s stock worth $2,748,000 after acquiring an additional 2,238 shares during the period. State Board of Administration of Florida Retirement System grew its holdings in Genesco by 25.4% during the 2nd quarter. State Board of Administration of Florida Retirement System now owns 11,649 shares of the company’s stock worth $462,000 after acquiring an additional 2,363 shares during the period. New York State Common Retirement Fund grew its holdings in Genesco by 13.2% during the 1st quarter. New York State Common Retirement Fund now owns 22,300 shares of the company’s stock worth $905,000 after acquiring an additional 2,600 shares during the period. Finally, NumerixS Investment Technologies Inc acquired a new stake in Genesco during the 2nd quarter worth about $106,000.
Genesco Company Profile
Genesco Inc retails and wholesales footwear, apparel, and accessories. The company operates in five segments: Journeys Group, Schuh Group, Lids Sports Group, Johnston & Murphy Group, and Licensed Brands. The Journeys Group segment offers footwear and accessories through the Journeys, Journeys Kidz, Shi by Journeys, and Little Burgundy retail chains, as well as through e-commerce and catalogs for young men, women, and children.
Recommended Story: What does relative strength index mean?
Receive News & Ratings for Genesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco and related companies with MarketBeat.com's FREE daily email newsletter.